Evaluation of the Relationship between Hemoglobin A1c  and Diabetic Retinopathy in Patients with Type Ⅱ  Diabetes at Tishreen University Hospital- Latakia- Syria

Faisal Redwan

doi:https://doi.org/10.14445/23939117/IJMS-V11I1P107

Research Article | Open Access

Volume 11 | Issue 1 | Year 2024 | Article Id. IJMS-V11I1P107 | DOI : https://doi.org/10.14445/23939117/IJMS-V11I1P107

Evaluation of the Relationship between Hemoglobin A1c and Diabetic Retinopathy in Patients with Type Ⅱ Diabetes at Tishreen University Hospital- Latakia- Syria

Faisal Redwan

Citation :

Faisal Redwan, "Evaluation of the Relationship between Hemoglobin A1c and Diabetic Retinopathy in Patients with Type Ⅱ Diabetes at Tishreen University Hospital- Latakia- Syria," International Journal of Medical Science, vol. 11, no. 1, pp. 36-39, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I1P107

Abstract

Background: Diabetic Retinopathy (DR) may be a common and specific microvascular complication of diabetes leading to blindness in working-aged people. Glycated hemoglobin (HbA1c) has an important role in diagnosing diabetes, but the assessment of its role in Diabetic Retinopathy (DR) is still unclear. Objective: This study aims to determine the prevalence of Diabetic retinopathy in Tishreen University Hospital- Latakia-Syria and evaluate its association with HbA1c. Methods: A cross-sectional survey was conducted on patients in the ophthalmic clinic of Tishreen University Hospital from May 2020 to December 2021. Results: The total number of diabetic patients in the current study was 222, 190 of them with type Ⅱ and 32 with type Ⅰ. Of 190 patients, 99 were males and 91 were females. The mean age of them was 64.46± 8.29 years, with a range (of 27-82) years. Of 222 patients, the prevalence of DR was 72.97%. As for the relationship between HbA1c levels and DR, a statistically significant association was recorded between them (p<0.001). Conclusion: It is important to control blood glucose and maintain HbA1c levels within the normal range. We recommend early diagnosis, treatment and prevention measures.

Keywords

Diabetic Retinopathy, DR, HbA1c, Glycated hemoglobin, Diabetes, Syria.

References

[1] Janusz Pieczyński, and Andrzej Grzybowski, “Review of Diabetic Retinopathy Screening Methods Programs Adopted in Different Parts of the World. Updated,” European Ophthalmic Review, vol. 9, no. 1, pp. 49-55, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Han Ul Kim, Sung Pyo Park, and Yong-Kyu Kim, “Long-Term HbA1c Variability and the Development and Progression of Diabetic Retinopathy in Subjects with Type 2 Diabetes,” Scientifc Reports, vol. 11, pp. 1-10, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[3] American Diabetes Association, “Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, vol. 33, no. 1, pp. S62-S69, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Chirag Singh et al., “Association of HbA1c Levels with Diabetic Retinopathy,” Indian Journal of Clinical and Experimental Ophthalmology, vol. 7, no. 2, pp. 339-345, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Alvin C. Powers, Kevin D. Niswender, and Carmella Evans-Molina, “Diabetes Mellitus: Diagnosis, Classification, and Patho Physiology,” Harrison’s Principles of Internal Medicine, Mcgraw-Hill Medical, pp. 2580-2558, 2020.
[Google Scholar] [Publisher Link]
[6] Bo Zhang et al., “The Value of Glycosylated Hemoglobin in the Diagnosis of Diabetic Retinopathy: A Systematic Review and Meta-Analysis,” BMC Endocrine Disorders, vol. 21, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Marcus Lind et al., “HbA1c Level as a Risk Factor for Retinopathy and Nephropathy in Children and Adults with Type 1 Diabetes: Swedish Population Based Cohort Study,” The BMJ, vol. 366, pp. 1-9, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[8] D.M. Nathan et al., “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus,” The New England Journal of Medicine, vol. 329, pp. 977-986, 1993.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Timothy S. Kern, David A. Antonetti, and Lois E.H. Smith, “Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research,” Ophthalmic Research, vol. 62, no. 4, pp. 196-202, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[10] D-10 Hemoglobin A1c Program L20012105 Instruction Manual. [Online]. Available: https://www.mdkhospital.com/documents/Hemoglobin%20A1c%20D10.pdf
[11] Boditech Med Inc, ichroma™ HbA1c, Document No. : INS-AA-EN.
[12] Pragati Garg et al., “Correlative Study of Diabetic Retinopathy with HbA1c and Microalbuminuria,” International Journal of Ophthalmic Research, vol. 4, no. 2, pp. 282-286, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[13] UK Prospective Diabetes Study Group, “Intensive Blood Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS33),” The Lancet, vol. 352, no. 9131, pp. 837-853, 1998.
[CrossRef] [Google Scholar] [Publisher Link]
[14] S. Lokesh, and S. Shivaswamy, “Study of HbA1C Levels in Patients with Type 2 Diabetes Mellitus in Relation to Diabetic Retinopathy in Indian Population,” International Journal of Advances in Medicine, vol. 5, no. 6, pp. 1-10, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[15] M. Long, C. Wang, and D. Liu, “Glycated Hemoglobin A1C and Vitamin D and Their Association with Diabetic Retinopathy Severity,” Nutrition & Diabetes, vol. 7, no. 6, pp. 1-7, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Saad Hajar et al., “Prevalence and Causes of Blindness and Diabetic Retinopathy in Southern Saudi Arabia,” Saudi Medical Journal, vol. 36, no. 4, pp. 449-455, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Wojciech Matuszewski et al., “Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland,” Medicina, vol. 56, no. 4, pp. 1-9, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[18] J.H. Kempen et al., “The Prevalence of Diabetic Retinopathy among Adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 552-563, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Robyn J. Tapp et al., “The Prevalence of and Factors Associated with Diabetic Retinopathy in the Australian Population,” Diabetes Care, vol. 26, no. 6, pp. 1731-1737, 2003.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Pedro Romero-Aroca et al., “Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-Up Study,” British Journal of Ophthalmology, vol. 101, no. 10, pp. 1346-1351, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Sarah Polack et al., “Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, Mexico,” Ophthalmology, vol. 119, no. 5, pp. 1033-1040, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Mansur M. Rabiu et al., “Prevalence of Blindness and Diabetic Retinopathy in Northern Jordan,” European Journal of Ophthalmology, vol. 25, no. 4, pp. 320-327, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Stuart A. Ross et al., “Diabetic Retinopathy in Native and Nonnative Canadians,” Journal of Diabetes Research, vol. 2007, pp. 1-7, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Masoud R. Manaviat, Mohammad Afkhami, and Mohammad R. Shoja, “Retinopathy and Microalbuminuria in Type II Diabetic Patients,” BMC Ophthalmology, vol. 4, pp. 1-4, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[25] Haibing Chen et al., “A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients,” PLoS ONE, vol. 7, no. 5, pp. 1-6, 2012.
[CrossRef] [Google Scholar] [Publisher Link]